doi: 10.1080/19490976.2022.2038856 Summary Keywords gut microbiota, metabolite, cardiovascular disease, trimethylamine N-oxide, targeted therapy Citation Zhen J, Zhou Z, He M, Han H-X, Lv E-H, Wen P-B, Liu X, Wang Y-T, Cai X-C, Tian J-Q, Zhang M-Y, Xiao L and Kang X-X (2023) The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
In terms of all MACE components together, we demonstrated that combination therapy was more effective than GLP-1RA monotherapy but not compared to SGLT-2i monotherapy
Linus Pauling Institute Oregon State University Updated in November 2014 by: Barbara Delage, Ph.D
How This Works BPC-157 is a synthetic pentadecapeptide (15 amino acids) originally isolated from human gastric juice
The Purity Guarantee Verified 99% by HPLC & mass spectrometry, third-party tested, with a lot-matched Certificate of Analysis on every vial